Will non-invasive testing replace liver biopsy in the diagnosis and follow-up of non-alcoholic steatohepatitis (NASH)?
F Pons
FP
Romero
D000328:Adult; D050110:Bariatric Surgery; D015415:Biomarkers; D001706:Biopsy; D015992:Body Mass Index; D002648:Child; D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D005234:Fatty Liver / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000209:etiology; D008137:Longitudinal Studies; D008297:Male; D015337:Multicenter Studies as Topic; D009767:Obesity, Morbid / Q000150:complications / Q000601:surgery; D015995:Prevalence; D011379:Prognosis; D013997:Time Factors
D015415:Biomarkers